GILEAD SCIENCES, INC. Quarterly Goodwill in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Gilead Sciences, Inc. quarterly Goodwill history and growth rate from Q2 2010 to Q4 2024.
  • Gilead Sciences, Inc. Goodwill for the quarter ending December 31, 2024 was $8.31B, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $8.31B $0 0% Dec 31, 2024 10-K 2025-02-28
Q3 2024 $8.31B $0 0% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $8.31B $0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $8.31B $0 0% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $8.31B $0 0% Dec 31, 2023 10-K 2025-02-28
Q3 2023 $8.31B $0 0% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $8.31B $0 0% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $8.31B $0 0% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $8.31B -$18M -0.22% Dec 31, 2022 10-K 2024-02-23
Q3 2022 $8.31B -$18M -0.22% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $8.31B -$20M -0.24% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $8.31B -$20M -0.24% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $8.33B +$224M +2.76% Dec 31, 2021 10-K 2024-02-23
Q3 2021 $8.33B +$4.22B +102% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $8.33B +$4.22B +102% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $8.33B +$4.22B +102% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $8.11B +$3.99B +96.9% Dec 31, 2020 10-K 2023-02-22
Q3 2020 $4.12B $0 0% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $4.12B $0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $4.12B $0 0% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $4.12B $0 0% Dec 31, 2019 10-K 2022-02-23
Q3 2019 $4.12B $0 0% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $4.12B -$7M -0.17% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $4.12B -$42M -1.01% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $4.12B -$42M -1.01% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $4.12B +$2.95B +251% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $4.12B +$2.95B +252% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 $4.16B +$2.99B +255% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $4.16B +$2.99B +255% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $1.17B $0 0% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $1.17B $0 0% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $1.17B $0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $1.17B $0 0% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $1.17B $0 0% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $1.17B $0 0% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $1.17B $0 0% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $1.17B $0 0% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $1.17B +$439K +0.04% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $1.17B +$439K +0.04% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $1.17B +$439K +0.04% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $1.17B +$3M +0.26% Dec 31, 2014 10-K 2016-02-24
Q3 2014 $1.17B -$16.6M -1.4% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $1.17B -$16.6M -1.4% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $1.17B -$16.6M -1.4% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $1.17B +$108M +10.2% Dec 31, 2013 10-K 2015-02-25
Q3 2013 $1.19B +$109M +10.1% Sep 30, 2013 10-Q 2013-10-31
Q2 2013 $1.19B +$109M +10.1% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $1.19B +$109M +10.1% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $1.06B +$56.8M +5.66% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $1.08B +$74.8M +7.45% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $1.08B +$74.8M +7.45% Jun 30, 2012 10-Q 2012-08-01
Q1 2012 $1.08B +$324M +43% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $1B +$471M +88.5% Dec 31, 2011 10-K 2013-02-27
Q3 2011 $1B +$471M +88.5% Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $1B +$542M +117% Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $754M Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $533M Dec 31, 2010 10-K 2012-02-23
Q3 2010 $533M Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $463M Jun 30, 2010 10-Q 2010-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.